Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
NCT06952842
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
NETWORK
Sponsor class
Conditions
Retinitis Pigmentosa
Interventions
DRUG:
ZVS203e
Sponsor
Chigenovo Co., Ltd